|
1
|
von Haehling S, Lainscak M, Springer J and
Anker SD: Cardiac cachexia: A systematic overview. Pharmacol Ther.
121:227–252. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
von Haehling S and Anker SD: Cachexia as a
major underestimated and unmet medical need: Facts and numbers. J
Cachexia Sarcopenia Muscle. 1:1–5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
von Haehling S, Anker MS and Anker SD:
Prevalence and clinical impact of cachexia in chronic illness in
Europe, USA, and Japan: Facts and numbers update 2016. J Cachexia
Sarcopenia Muscle. 7:507–509. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fearon KC: Cancer cachexia: Developing
multimodal therapy for a multidimensional problem. Eur J Cancer.
44:1124–1132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tisdale MJ: Cachexia in cancer patients.
Nat Rev Cancer. 2:862–871. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ksiazek-Winiarek DJ, Kacperska MJ and
Glabinski A: MicroRNAs as novel regulators of neuroinflammation.
Mediators Inflamm. 2013:1723512013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:pp. 15524–15529. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mirnezami AH, Pickard K, Zhang L, Primrose
JN and Packham G: MicroRNAs: Key players in carcinogenesis and
novel therapeutic targets. Eur J Surg Oncol. 35:339–347. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Belaguli N and Berger DH: MicroRNA
and colorectal cancer. World J Surg. 33:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. Jama. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cummins JM, He Y, Leary RJ, Pagliarini R,
Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE,
Labourier E, et al: The colorectal microRNAome. Proc Natl Acad Sci
USA. 103:pp. 3687–3692. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valadi H, Ekstrom K, Bossios A, Sjostrand
M, Lee JJ and Lotvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Montecalvo A, Larregina AT, Shufesky WJ,
Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G,
Wang Z, et al: Mechanism of transfer of functional microRNAs
between mouse dendritic cells via exosomes. Blood. 119:756–766.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Castellana D, Zobairi F, Martinez MC,
Panaro MA, Mitolo V, Freyssinet JM and Kunzelmann C: Membrane
microvesicles as actors in the establishment of a favorable
prostatic tumoral niche: A role for activated fibroblasts and
CX3CL1-CX3CR1 axis. Cancer Res. 69:785–793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andre N and Schmiegel W: Chemoradiotherapy
for colorectal cancer. Gut. 54:1194–1202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lurje G, Zhang W and Lenz HJ: Molecular
prognostic markers in locally advanced colon cancer. Clin
Colorectal Cancer. 6:683–690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miki C, Tonouchi H, Wakuda R, Hatada T,
Inoue Y, Minato E, Kobayashi M and Kusunoki M: Intra-tumoral
interleukin-6 down-regulation system and genetic mutations of tumor
suppressor genes in colorectal carcinoma. Cancer. 94:1584–1592.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okugawa Y, Miki C, Toiyama Y, Yasuda H,
Yokoe T, Saigusa S, Hiro J, Tanaka K, Inoue Y and Kusunoki M: Loss
of tumoral expression of soluble IL-6 receptor is associated with
disease progression in colorectal cancer. Br J Cancer. 103:787–795.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koike Y, Miki C, Okugawa Y, Yokoe T,
Toiyama Y, Tanaka K, Inoue Y and Kusunoki M: Preoperative
C-reactive protein as a prognostic and therapeutic marker for
colorectal cancer. J Surg Oncol. 98:540–544. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shirai Y, Okugawa Y, Hishida A, Ogawa A,
Okamoto K, Shintani M, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K,
et al: Fish oil-enriched nutrition combined with systemic
chemotherapy for gastrointestinal cancer patients with cancer
cachexia. Sci Rep. 7:48262017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hur K, Toiyama Y, Schetter AJ, Okugawa Y,
Harris CC, Boland CR and Goel A: Identification of a
metastasis-specific MicroRNA signature in human colorectal cancer.
J Natl Cancer Inst. 107:dju492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okugawa Y, Toiyama Y, Toden S, Mitoma H,
Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A:
Clinical significance of SNORA42 as an oncogene and a prognostic
biomarker in colorectal cancer. Gut. 66:107–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamada A, Horimatsu T, Okugawa Y, Nishida
N, Honjo H, Ida H, Kou T, Kusaka T, Sasaki Y, Yagi M, et al: Serum
miR-21, miR-29a, and miR-125b are promising biomarkers for the
early detection of colorectal neoplasia. Clin Cancer Res.
21:4234–4242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka
H, Boland CR and Goel A: Circulating microRNA-203 predicts
prognosis and metastasis in human colorectal cancer. Gut.
66:654–665. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). 2010.
|
|
31
|
Fujikawa H, Araki T, Okita Y, Kondo S,
Kawamura M, Hiro J, Toiyama Y, Kobayashi M, Tanaka K, Inoue Y, et
al: Impact of sarcopenia on surgical site infection after
restorative proctocolectomy for ulcerative colitis. Surg Today.
47:92–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okumura S, Kaido T, Hamaguchi Y, Fujimoto
Y, Masui T, Mizumoto M, Hammad A, Mori A, Takaori K and Uemoto S:
Impact of preoperative quality as well as quantity of skeletal
muscle on survival after resection of pancreatic cancer. Surgery.
157:1088–1098. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobayashi A, Kaido T, Hamaguchi Y, Okumura
S, Taura K, Hatano E, Okajima H and Uemoto S: Impact of
postoperative changes in sarcopenic factors on outcomes after
hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat
Sci. 23:57–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hamaguchi Y, Kaido T, Okumura S, Kobayashi
A, Hammad A, Tamai Y, Inagaki N and Uemoto S: Proposal for new
diagnostic criteria for low skeletal muscle mass based on computed
tomography imaging in Asian adults. Nutrition. 32:1200–1205. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kitajima Y, Eguchi Y, Ishibashi E,
Nakashita S, Aoki S, Toda S, Mizuta T, Ozaki I, Ono N, Eguchi T, et
al: Age-related fat deposition in multifidus muscle could be a
marker for nonalcoholic fatty liver disease. J Gastroenterol.
45:218–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kitajima Y, Hyogo H, Sumida Y, Eguchi Y,
Ono N, Kuwashiro T, Tanaka K, Takahashi H, Mizuta T, Ozaki I, et
al: Severity of non-alcoholic steatohepatitis is associated with
substitution of adipose tissue in skeletal muscle. J Gastroenterol
Hepatol. 28:1507–1514. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kroh EM, Parkin RK, Mitchell PS and Tewari
M: Analysis of circulating microRNA biomarkers in plasma and serum
using quantitative reverse transcription-PCR (qRT-PCR). Methods.
50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Link A, Balaguer F, Shen Y, Nagasaka T,
Lozano JJ, Boland CR and Goel A: Fecal MicroRNAs as novel
biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers
Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang KH, Mestdagh P, Vandesompele J,
Kerin MJ and Miller N: MicroRNA expression profiling to identify
and validate reference genes for relative quantification in
colorectal cancer. BMC Cancer. 10:1732010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Okugawa Y, Grady WM and Goel A: Epigenetic
alterations in colorectal cancer: Emerging Biomarkers.
Gastroenterology. 149:1204–1225.e12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He WA, Calore F, Londhe P, Canella A,
Guttridge DC and Croce CM: Microvesicles containing miRNAs promote
muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci
USA. 111:pp. 4525–4529. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Prado CM, Lieffers JR, McCargar LJ, Reiman
T, Sawyer MB, Martin L and Baracos VE: Prevalence and clinical
implications of sarcopenic obesity in patients with solid tumours
of the respiratory and gastrointestinal tracts: A population-based
study. Lancet Oncol. 9:629–635. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Thoresen L, Frykholm G, Lydersen S,
Ulveland H, Baracos V, Prado CM, Birdsell L and Falkmer U:
Nutritional status, cachexia and survival in patients with advanced
colorectal carcinoma. Different assessment criteria for nutritional
status provide unequal results. Clin Nutr. 32:65–72. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fearon K, Arends J and Baracos V:
Understanding the mechanisms and treatment options in cancer
cachexia. Nat Rev Clin Oncol. 10:90–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van Vledder MG, Levolger S, Ayez N,
Verhoef C, Tran TC and Ijzermans JN: Body composition and outcome
in patients undergoing resection of colorectal liver metastases. Br
J Surg. 99:550–557. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Voron T, Tselikas L, Pietrasz D, Pigneur
F, Laurent A, Compagnon P, Salloum C, Luciani A and Azoulay D:
Sarcopenia impacts on short- and long-term results of hepatectomy
for hepatocellular carcinoma. Ann Surg. 261:1173–1183. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tan BH, Birdsell LA, Martin L, Baracos VE
and Fearon KC: Sarcopenia in an overweight or obese patient is an
adverse prognostic factor in pancreatic cancer. Clin Cancer Res.
15:6973–6979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lieffers JR, Bathe OF, Fassbender K,
Winget M and Baracos VE: Sarcopenia is associated with
postoperative infection and delayed recovery from colorectal cancer
resection surgery. Br J Cancer. 107:931–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hamaguchi Y, Kaido T, Okumura S, Ito T,
Fujimoto Y, Ogawa K, Mori A, Hammad A, Hatano E and Uemoto S:
Preoperative intramuscular adipose tissue content is a novel
prognostic predictor after hepatectomy for hepatocellular
carcinoma. J Hepatobiliary Pancreat Sci. 22:475–485. 2015.
View Article : Google Scholar : PubMed/NCBI
|
